Aurangabad, India

Anusuya Patel

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Wockhardt Limited. Active years: 2019.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Anusuya Patel: Innovator in Antibacterial Compounds

Introduction

Anusuya Patel is a prominent inventor based in Aurangabad, India. She has made significant contributions to the field of pharmaceuticals, particularly in the development of antibacterial compounds. Her innovative work is aimed at addressing the growing concern of bacterial infections.

Latest Patents

Anusuya Patel holds a patent for antibacterial compounds, specifically compounds of Formula (I), or a stereoisomer or a pharmaceutically acceptable salt thereof. This patent also covers their preparation, pharmaceutical compositions comprising such compounds, and their use in treating and/or preventing bacterial infections. This invention highlights her commitment to advancing medical science and improving public health.

Career Highlights

Anusuya Patel is currently employed at Wockhardt Limited, a well-known pharmaceutical company. Her role at Wockhardt has allowed her to focus on research and development, contributing to the company's mission of delivering high-quality healthcare solutions.

Collaborations

Throughout her career, Anusuya has collaborated with notable colleagues, including Vijaykumar Jagdishwar Patil and Ravikumar Tadiparthi. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.

Conclusion

Anusuya Patel's work in antibacterial compounds exemplifies her dedication to innovation in the pharmaceutical industry. Her contributions are vital in the ongoing battle against bacterial infections, showcasing the importance of research and development in healthcare.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…